tocilizumab,cevostamab
roche
['mmsm', 'tocilizumab', 'toci', 'multiple myeloma', 'cevostamab', 'genentech']
good news for patients using cevostamab. cytokine release syndrome (crs) can be decreased in frequency with no impact on the response rate by having a pretreatment with tocilizumab according to the results shown by suzanne trudel #ash22 #mmsm 
Supporting, educating and connecting myeloma patients and their loved ones while actively seeking a cure. #myeloma #mmsm #hematology #multiplemyeloma